Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Overweight and Obese Subjects Dosed with ASC41 Tablets in a Phase Ib Trial

prnasiaDecember 22, 2020

Tag: Ascletis , NASH , ASC41 , Gannex

PharmaSources Customer Service